Partnerships, interagency coordination and resource mobilization
Sources of Voluntary Contributions (2014-2015)
WHO Leadership Priorities
Universal health coverage
The International Health
Regulations (2005)
We continue to partner with of Member States, Development Partners, Non-State Actors, and Multilateral
Organizations to contribute to national eforts by Member States towards improving the health status of
people in the region.
Member States
Bangladesh
Increasing access to
medical products
Noncommunicable
diseases including
disabilities, mental health,
violence and injuries
Social, economics
and environmental
determinants
Health-related Millennium
Development Goals
Bhutan
Estonia
Finland
India
Indonesia
Italy
Japan
Luxembourg
Maldives
Nepal
Republic of korea
Russian federation
Sri lanka
Thailand
Timor-leste
Development Partners
Centres for Disease Control and Prevention (CDC), USA
Department of Foreign Afairs, Trade and Development
(DFATD), Canada
Department of Foreign Afairs and Trade (DFAT), Australia
Department for International Development (DfID), United
Kingdom
Deutsche Gesellschaft Fur Internationale Zusammenarbeit
(GIZ), Germany
European Commission (EC)
European Commission – Europeaid Cooperation Oice (AIDCO)
European Commission – Humanitarian Aid Oice (ECHO)
France Expertise Internationale (FEI)
GAVI Alliance
Global Fund to ight AIDS, Tuberculosis and Malaria (GFATM)
Intervida, Spain
Norwegian Agency for Development Cooperation (NORAD),
Norway
OPEC Fund for International Development (OFIC), OPEC
Swedish International Development Cooperation Agency
(SIDA), Sweden
United States Department of Health and Human Services
(USDHHS), USA
United States Agency for International Development (USAID), USA
Non-state Actors
Technical Programme Areas
• HIV/AIDS
• Tuberculosis
• Malaria
• Neglected tropical diseases
• Vaccine-preventable diseases
Communicable diseases
Noncommunicable
diseases
WHO
Promoting health through
the life-course
Health systems
Preparedness, surveillance
and response
• Noncommunicable diseases
• Mental health and substance abuse
• Violence and injuries
• Disabilities and rehabilitation
• Nutrition
• Reproductive, maternal, newborn, child and
adolescent health
• Ageing and health
• Gender, equity and human rights
mainstreaming
• Social determinants of health
• Health and the environment
• National health policies, strategies and plans
• Integrated people-centered health services
• Access to medicines and health technologies
and strengthening regulatory capacity
• Health systems, information and evidence
• Alert and response capacities
• Epidemic-prone and pandemic-prone diseases
• Emergency risk and crisis management
• Food safety
• Polio eradication
• Outbreak and crisis response
Autism Speaks
Bill and Melinda Gates Foundation
Bloomberg Family Foundation
CDC Foundation
EISAI Co., Ltd.
Eli Lilly and Company Foundation
FIA Foundation for The Automobile and Society
Fondation Raoul Follereau
Glaxosmithkline (GSK)
Gilead Sciences Inc.
International Union Against Tuberculosis and Lung Disease
(IUATLD)
Johnson and Johnson Family of Companies Contribution Fund
Kathmandu Upatyaka Kahnepani Limited
KNCV Tuberculosis Foundation
KOBE Group (Hyogo Prefecture, KOBE City, KOBE Chamber of
Commerce and Industry and KOBE Steel, Ltd.)
MERCK
Micronutrient Initiative (MI)
MMV Medicines for Malaria Venture
Nippon Foundation
Novartis
Population Services International (PSI)
Program for Appropriate Technology in Health (PATH)
Rotary International
Sabin Vaccine Institute
Sanoi Winthrop Industrie
Sasakawa Memorial Health Foundation
UCB, SA
University Research Co. LLC
World Lung Foundation
Multilateral Organizations
The Joint United Nations Programme on HIV/AIDS (UNAIDS)
United Nations Central Emergency Resource Fund (CERF)
United Nations Children’s Fund (UNICEF)
United Nations Development Programme (UNDP)
United Nations Environment Programme (UNEP)
United Nations Fund for International Partnerships (UNFIP)
United Nations Oice for Project Services (UNOPS)
United Nations Population Fund (UNFPA)
United Nations Trust Fund for Human Security (UNTFHS)
World Meteorological Organization (WMO)
1 Progress in health-related MDGs in the WHO South-East Region. New Delhi: World Health Organization; 2012.
2 Where have all the donors gone? Scarce donor funding for non-communicable diseases (Working Paper 228) Washington DC: Center for
Global Development; 2010.
3. WHO SEARO Strategic Vision, Regional Director SEA Region brochure
Healthcare for all:
A multi-sectoral partnership
WHO in South-East Asia
The Impact
Since 1948, the WHO Regional Oice for South-East Asia (SEARO) has been working with Member countries
to ensure all people have the highest possible level of health across the region.
WHO has provided leadership on health matters, articulated evidence-based policy options, shared new
knowledge, set standards, provided technical support to countries and monitored health trends.
These combined eforts have contributed to some remarkable achievements across the region:
160,996,000
1,092.7
775,000
3.7%
2,380.9
Indonesia
India
1,311,051,000
1,595.7
4.0%
3,491.9
25,155,000
3.6%
n/a
n/a
Myanmar
Maldives
257,564,000
364,000
3.1%
• Eradication of smallpox and polio with immunization interventions reaching more than 80% cover
regionally
• Near eradication of guinea-worm disease and leprosy with countries stating both are no longer a
public health concern;
• Improved life-expectancy and the under-ive mortality rate has fallen by 32% across the region;
• Halted HIV epidemic with the number of new HIV infections falling by 31% in the past decade;
• Continued treatment success of TB has remained above 85% resulting in 100,000 lives saved every year;
• Reduction in Malaria-caused deaths with ive countries reporting at 75% decrease in malaria cases.
Democratic People's
Republic of Korea
Bhutan
Bangladesh
8,483.8
53,897,000
10.8%
1,203.8
1.8%
Directions
Strategic Vision
1 by 4 Strategic Vision
Nepal
20,715,000
28,514,000
696.9
Thailand
Sri Lanka
6.0%
3,631.05
Timor-Leste
67,959,000
3.2%
5,519.4
No of Population
GDP per capita
(Source: United Nations, Department of
Economic and Social Affairs, Population
Division (2015). World Population
Prospects: The 2015 Revision, DVD Edition.)
(Source: World Development
Indicators, The World Bank)
1,185,000
4.6%
1,280.42
Addressing persistent and emerging
epidemiological challenges;
Strengthening emergency risk
management for sustainable
development;
Advancing universal health coverage
and robust health systems;
Articulating a strong regional voice in
the global health agenda.
1.3%
Total expenditure on health
as a percentage of gross
domestic product
(Source: World Health Organization)
Flagship priority areas to implement
Measles elimination and rubella control by 2020
Prevention of noncommunicable diseases through multisectoral policies and plans with focus on ‘best buys’
This WHO region
has a population
and bears about
of the global
30%
disease burden
over
1.5 billion
40%
making up
of the world’s poor
The uninished MDGs agenda: ending preventable maternal, newborn and child dealths with focus on
neonatal deaths
Universal Health Coverage with focus on human resources for health and essential medicines
Building national capacity for preventing and combating Antimicrobial Resistance
Scaling up capacity development in emergency risk management in countries
Finishing the task of eliminating diseases on the verge of elimination (Kala-azer, Leprosy, Lymphatic Filriasis and Yaws)
WORKING
TOGETHER
WHO Leadership Priorities
Universal health coverage
The International Health
Regulations (2005)
We continue to partner with of Member States, Development Partners, Non-State Actors, and Multilateral
Organizations to contribute to national eforts by Member States towards improving the health status of
people in the region.
Member States
Bangladesh
Increasing access to
medical products
Noncommunicable
diseases including
disabilities, mental health,
violence and injuries
Social, economics
and environmental
determinants
Health-related Millennium
Development Goals
Bhutan
Estonia
Finland
India
Indonesia
Italy
Japan
Luxembourg
Maldives
Nepal
Republic of korea
Russian federation
Sri lanka
Thailand
Timor-leste
Development Partners
Centres for Disease Control and Prevention (CDC), USA
Department of Foreign Afairs, Trade and Development
(DFATD), Canada
Department of Foreign Afairs and Trade (DFAT), Australia
Department for International Development (DfID), United
Kingdom
Deutsche Gesellschaft Fur Internationale Zusammenarbeit
(GIZ), Germany
European Commission (EC)
European Commission – Europeaid Cooperation Oice (AIDCO)
European Commission – Humanitarian Aid Oice (ECHO)
France Expertise Internationale (FEI)
GAVI Alliance
Global Fund to ight AIDS, Tuberculosis and Malaria (GFATM)
Intervida, Spain
Norwegian Agency for Development Cooperation (NORAD),
Norway
OPEC Fund for International Development (OFIC), OPEC
Swedish International Development Cooperation Agency
(SIDA), Sweden
United States Department of Health and Human Services
(USDHHS), USA
United States Agency for International Development (USAID), USA
Non-state Actors
Technical Programme Areas
• HIV/AIDS
• Tuberculosis
• Malaria
• Neglected tropical diseases
• Vaccine-preventable diseases
Communicable diseases
Noncommunicable
diseases
WHO
Promoting health through
the life-course
Health systems
Preparedness, surveillance
and response
• Noncommunicable diseases
• Mental health and substance abuse
• Violence and injuries
• Disabilities and rehabilitation
• Nutrition
• Reproductive, maternal, newborn, child and
adolescent health
• Ageing and health
• Gender, equity and human rights
mainstreaming
• Social determinants of health
• Health and the environment
• National health policies, strategies and plans
• Integrated people-centered health services
• Access to medicines and health technologies
and strengthening regulatory capacity
• Health systems, information and evidence
• Alert and response capacities
• Epidemic-prone and pandemic-prone diseases
• Emergency risk and crisis management
• Food safety
• Polio eradication
• Outbreak and crisis response
Autism Speaks
Bill and Melinda Gates Foundation
Bloomberg Family Foundation
CDC Foundation
EISAI Co., Ltd.
Eli Lilly and Company Foundation
FIA Foundation for The Automobile and Society
Fondation Raoul Follereau
Glaxosmithkline (GSK)
Gilead Sciences Inc.
International Union Against Tuberculosis and Lung Disease
(IUATLD)
Johnson and Johnson Family of Companies Contribution Fund
Kathmandu Upatyaka Kahnepani Limited
KNCV Tuberculosis Foundation
KOBE Group (Hyogo Prefecture, KOBE City, KOBE Chamber of
Commerce and Industry and KOBE Steel, Ltd.)
MERCK
Micronutrient Initiative (MI)
MMV Medicines for Malaria Venture
Nippon Foundation
Novartis
Population Services International (PSI)
Program for Appropriate Technology in Health (PATH)
Rotary International
Sabin Vaccine Institute
Sanoi Winthrop Industrie
Sasakawa Memorial Health Foundation
UCB, SA
University Research Co. LLC
World Lung Foundation
Multilateral Organizations
The Joint United Nations Programme on HIV/AIDS (UNAIDS)
United Nations Central Emergency Resource Fund (CERF)
United Nations Children’s Fund (UNICEF)
United Nations Development Programme (UNDP)
United Nations Environment Programme (UNEP)
United Nations Fund for International Partnerships (UNFIP)
United Nations Oice for Project Services (UNOPS)
United Nations Population Fund (UNFPA)
United Nations Trust Fund for Human Security (UNTFHS)
World Meteorological Organization (WMO)
1 Progress in health-related MDGs in the WHO South-East Region. New Delhi: World Health Organization; 2012.
2 Where have all the donors gone? Scarce donor funding for non-communicable diseases (Working Paper 228) Washington DC: Center for
Global Development; 2010.
3. WHO SEARO Strategic Vision, Regional Director SEA Region brochure
Healthcare for all:
A multi-sectoral partnership
WHO in South-East Asia
The Impact
Since 1948, the WHO Regional Oice for South-East Asia (SEARO) has been working with Member countries
to ensure all people have the highest possible level of health across the region.
WHO has provided leadership on health matters, articulated evidence-based policy options, shared new
knowledge, set standards, provided technical support to countries and monitored health trends.
These combined eforts have contributed to some remarkable achievements across the region:
160,996,000
1,092.7
775,000
3.7%
2,380.9
Indonesia
India
1,311,051,000
1,595.7
4.0%
3,491.9
25,155,000
3.6%
n/a
n/a
Myanmar
Maldives
257,564,000
364,000
3.1%
• Eradication of smallpox and polio with immunization interventions reaching more than 80% cover
regionally
• Near eradication of guinea-worm disease and leprosy with countries stating both are no longer a
public health concern;
• Improved life-expectancy and the under-ive mortality rate has fallen by 32% across the region;
• Halted HIV epidemic with the number of new HIV infections falling by 31% in the past decade;
• Continued treatment success of TB has remained above 85% resulting in 100,000 lives saved every year;
• Reduction in Malaria-caused deaths with ive countries reporting at 75% decrease in malaria cases.
Democratic People's
Republic of Korea
Bhutan
Bangladesh
8,483.8
53,897,000
10.8%
1,203.8
1.8%
Directions
Strategic Vision
1 by 4 Strategic Vision
Nepal
20,715,000
28,514,000
696.9
Thailand
Sri Lanka
6.0%
3,631.05
Timor-Leste
67,959,000
3.2%
5,519.4
No of Population
GDP per capita
(Source: United Nations, Department of
Economic and Social Affairs, Population
Division (2015). World Population
Prospects: The 2015 Revision, DVD Edition.)
(Source: World Development
Indicators, The World Bank)
1,185,000
4.6%
1,280.42
Addressing persistent and emerging
epidemiological challenges;
Strengthening emergency risk
management for sustainable
development;
Advancing universal health coverage
and robust health systems;
Articulating a strong regional voice in
the global health agenda.
1.3%
Total expenditure on health
as a percentage of gross
domestic product
(Source: World Health Organization)
Flagship priority areas to implement
Measles elimination and rubella control by 2020
Prevention of noncommunicable diseases through multisectoral policies and plans with focus on ‘best buys’
This WHO region
has a population
and bears about
of the global
30%
disease burden
over
1.5 billion
40%
making up
of the world’s poor
The uninished MDGs agenda: ending preventable maternal, newborn and child dealths with focus on
neonatal deaths
Universal Health Coverage with focus on human resources for health and essential medicines
Building national capacity for preventing and combating Antimicrobial Resistance
Scaling up capacity development in emergency risk management in countries
Finishing the task of eliminating diseases on the verge of elimination (Kala-azer, Leprosy, Lymphatic Filriasis and Yaws)
WORKING
TOGETHER